Early phase trials have always been critical within pharmaceutical development, establishing the safety and potential efficacy of a new molecule or treatment with a view to further research and eve
The WHO reports that in 2015, cancer was the second highest cause of death globally – responsible for 8.8 million fatalities, yet we are at a point in time where the speed of advancement in underst
